| Irinotecan | None | ||
| 43MG/10ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ONIVYDE is a topoisomerase inhibitor indicated, in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. | |||
|
Yes
| |||
| Onivyde | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||
| ********* ****** *** **** ******** | ********* ****** *** **** ******** | ******* *** ******** ********** ****** ***** *********** ********* ********** ********* ********** | ******* *** ******** ********** ****** ***** *********** ********* ********** ********* ********** | ******* *** ******** ********** ****** ***** *********** ********* ********** ********* ********** | ******* *** ******** ********** ****** ***** *********** ********* ********** ********* ********** | ******* *** ******** ********** ****** ***** *********** ********* | *********** ************ ************** ************ | ******* *** ******** ********** ****** ***** *********** ********* ********** ********* ********** | *********** ************ ************** ************ | ******* *** ******** ********** ********** ****** ***** *********** ********* ********** ********* ********** *** *********** | ******* *** ******** ********** ****** ***** *********** ********* | *********** ************ ************** ************ | ******* *** ******** ********** ****** ***** *********** ********* | ********* ****** *** **** ******** | ********* ****** *** **** ******** | ********* ****** *** **** ******** | ********* ****** *** **** ******** | ********* ****** *** **** ******** | ********* ****** *** **** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|